A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines

Options for the control of influenza III

Gordon Ada, Gregory A. Tannock, Alan Hampson · Vaccine · 1997 · 587 citations

Medicine, Infectious Disease Control, Infectious Diseases +12

The annual production cycle for influenza vaccine

C. Gerdil · Vaccine · 2003 · 533 citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +14

Vaccine manufacturing: challenges and solutions

Jeffrey B. Ulmer, Ulrich Valley, Rino Rappuoli · Nature Biotechnology · 2006 · 375 citations

Veterinary Medicine, Immunology, Vaccine Biotechnology +11

Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus

Jacqueline M. Katz, M Wang, Robert G. Webster · Journal of Virology · 1990 · 176 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +11

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system

Carolyn Nicolson, Diane Major, John Wood et al. · Vaccine · 2004 · 156 citations

Veterinary Medicine, Biotechnology, Infectious Diseases +13